TY - JOUR
T1 - Impact of patents on Indian pharma industry's growth and competency: A viewpoint of pharmaceutical companies in India
AU - Janodia, Manthan D.
AU - Rao, J. Venkata
AU - Pandey, Sureshwar
AU - Sreedhar, D.
AU - Ligade, Virendra S.
AU - Udupa, N.
N1 - Cited By :5
Export Date: 10 November 2017
Correspondence Address: Janodia, M. D.; Manipal College of Pharmaceutical Sciences, Manipal University, Manipal 576 104, India; email: mdjanodia1978@yahoo.co.in
References: Malhotra, N.K., (2001) Marketing Research, an Applied Orientation, , (Pearson Education, Singapore), First Indian reprint; Boyd, H., Basic methods of collecting data (2000) Marketing Research Text and Cases, , edited by H W Boyd, R Westfall and S Stasch (Richard Irwin Inc, Illinois); Tull, D., The sampling process (1999) Marketing Research Measurement and Method, , edited by D S Tull and D I Hawkins (Macmillan Publishing Company, New York); Aaker, D., Fundamental of data analysis (2001) Marketing Research, , edited by D Aaker, V Kumar and G Day (John Wiley & Sons, Canada); Chaudhuri, S., Is product patent protection necessary in developing countries for innovation? (2008) Presented in Conference on R&D by Indian Pharmaceutical Companies after TRIPS, , http://www.iprsonline.org/resources/docs/Sudip-WP-India-R&D-TRIPS- Sept-007.pdf, Indian Institute of Management, Kolkata, WPS No. 614/ September 2007, 16, 21 May; (2008), www1.imshealth.com, World Pharmaceutical Market Summary, Sales through Retail PharmaciesUR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77951843430&partnerID=40&md5=8aa3c7f2421b39edc4e2c87801e9b707
PY - 2009/9
Y1 - 2009/9
N2 - Instruments of intellectual property rights (IPR) are considered to achieve economic, social and technological advancement for a country in all aspects. Of all the instruments of IPR, patent is the most contentious issue which is deliberated in several international fora. Patents are mostly debated for their role in pharmaceutical field. India signed General Agreement on Tariffs and Trade (GATT) in 1994 agreeing to implement the IPR in all fields of technology, including product patent, with effect from 1 January 1995. Taking into account India's status as a developing country, India was granted a transition period of ten years from 1995 to 2005 to switch over from process patent to product patent. With this shift, it was imperative for Indian pharmaceutical companies to embrace product patents. This study was undertaken with the objective of identifying the situation in India after product patent regime was implemented. The role of Indian pharmaceutical companies in the era of product patent is crucial. The authors attempted to identify how Indian pharmaceutical companies view product patent regime, hindering the growth of industry or providing impetus to R&D, in this study. The measures taken by these companies to survive and grow in product patent regime have also been analysed.
AB - Instruments of intellectual property rights (IPR) are considered to achieve economic, social and technological advancement for a country in all aspects. Of all the instruments of IPR, patent is the most contentious issue which is deliberated in several international fora. Patents are mostly debated for their role in pharmaceutical field. India signed General Agreement on Tariffs and Trade (GATT) in 1994 agreeing to implement the IPR in all fields of technology, including product patent, with effect from 1 January 1995. Taking into account India's status as a developing country, India was granted a transition period of ten years from 1995 to 2005 to switch over from process patent to product patent. With this shift, it was imperative for Indian pharmaceutical companies to embrace product patents. This study was undertaken with the objective of identifying the situation in India after product patent regime was implemented. The role of Indian pharmaceutical companies in the era of product patent is crucial. The authors attempted to identify how Indian pharmaceutical companies view product patent regime, hindering the growth of industry or providing impetus to R&D, in this study. The measures taken by these companies to survive and grow in product patent regime have also been analysed.
UR - http://www.scopus.com/inward/record.url?scp=77951843430&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77951843430&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:77951843430
SN - 0971-7544
VL - 14
SP - 432
EP - 436
JO - Journal of Intellectual Property Rights
JF - Journal of Intellectual Property Rights
IS - 5
ER -
